Correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis. 1990

G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
Department of Biochemistry, University of Minnesota, Navarre 55392.

Spatially localized nuclear magnetic resonance spectroscopy was used to investigate with transmural differentiation the response of myocardial high energy phosphate compounds and inorganic orthophosphate (Pi) to graded reductions in coronary blood flow caused by sustained coronary stenosis. In an open-chest model, localized 31P nuclear magnetic resonance spectra from five layers across the left ventricular wall were obtained simultaneously with transmural blood flow measurements during control conditions and during sustained graded reductions in intracoronary pressure. Both the blood flow, and high energy phosphate and Pi contents displayed transmural heterogeneity in response to decreases in intracoronary pressure. The subendocardial creatine phosphate (CP) level remained unchanged as blood flow was reduced to approximately 0.7 ml/min/g wet wt and decreased precipitously beyond this critical flow level. The relation between CP and flow in the midmyocardium and especially in the subepicardium was more complex. Subepicardial CP content did not correlate well with blood flow; however, in cases in which a coronary stenosis resulted in subendocardial hypoperfusion but subepicardial flow was near or above normal, a close correlation was present between subepicardial and subendocardial CP levels. ATP levels in all layers remained unaltered until blood flow was severely reduced. These results demonstrate that 1) the myocardial high energy phosphate and Pi levels at any transmural layer are not generally determined by O2 and blood flow limitation under basal conditions; 2) during subtotal coronary occlusion, increased oxygen extraction is able to meet myocardial needs until a critical level of stenosis is reached; 3) below a critical flow level, subendocardial CP and Pi contents are closely correlated with absolute subendocardial blood flow; and 4) in the presence of a coronary stenosis, subepicardial CP and Pi contents may change even in the absence of perfusion deficit secondary to loss of subendocardial function.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010085 Oxidative Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. Phosphorylation, Oxidative,Oxidative Phosphorylations,Phosphorylations, Oxidative
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003251 Constriction, Pathologic The condition of an anatomical structure's being constricted beyond normal dimensions. Stenosis,Stricture,Constriction, Pathological,Pathologic Constriction,Constrictions, Pathologic,Pathologic Constrictions,Pathological Constriction,Stenoses,Strictures
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog

Related Publications

G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
January 2001, American journal of physiology. Heart and circulatory physiology,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
November 1999, Japanese heart journal,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
May 1982, Circulation,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
January 1976, Recent advances in studies on cardiac structure and metabolism,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
January 1977, Basic research in cardiology,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
October 1990, Clinical and experimental pharmacology & physiology,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
January 1997, The American journal of physiology,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
January 1982, Cor et vasa,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
February 1970, The Journal of pharmacology and experimental therapeutics,
G Path, and P M Robitaille, and H Merkle, and M Tristani, and J Zhang, and M Garwood, and A H From, and R J Bache, and K Uğurbil
June 1994, The New England journal of medicine,
Copied contents to your clipboard!